Brazilian Regulator Wins Place On ICH Management Committee
The Move Gives Brazil Decision Making Power In Global Regulations
Executive Summary
Brazil’s pharmaceutical industry has welcomed the election of medicines regulator ANVISA to the management committee of the International Council for Harmonization.
You may also be interested in...
Differences Put Aside As ICH Finalizes Guide On Post Approval Changes
An international guideline on managing post approval changes to drugs, which was initially criticized because of its incompatibility with legal frameworks in certain ICH regions such as the EU, has been finalized.
Brazil Gets Down To Implementing ICH Guidelines
Brazil’s medicines regulator ANVISA has begun the process of implementing International Council for Harmonisation guidelines on areas such as clinical safety data management and the Common Technical Document.
Lack Of Industry Involvement In EU HTA Scoping Process Exacerbates ‘Unworkable’ Timelines
Scientific advice could help companies make up for the lack of involvement in scoping, but slots are in short supply.